Monitoring disease activity in multiple sclerosis using serum neurofilament light protein von Novakova, Lenka, Zetterberg, Henrik, Sundström, Peter, Axelsson, Markus, Khademi, Mohsen, Gunnarsson, Martin, Malmeström, Clas, Svenningsson, Anders, Olsson, Tomas, Piehl, Fredrik, Blennow, Kaj, Lycke, Jan

Volltext

Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study von Sundström, Peter, Wåhlin, Anders, Ambarki, Khalid, Birgander, Richard, Eklund, Anders, Malm, Jan

Volltext

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis von Boremalm, Malin, Sundström, Peter, Salzer, Jonatan

Volltext

Vitamin D as a protective factor in multiple sclerosis von SALZER, Jonatan, HALLMANS, Göran, NYSTROM, Maria, STENLUND, Hans, WADELL, Göran, SUNDSTRÖM, Peter

Volltext

Neurofilament light as a prognostic marker in multiple sclerosis von Salzer, Jonatan, Svenningsson, Anders, Sundström, Peter

Volltext

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab von Gunnarsson, Martin, Malmeström, Clas, Axelsson, Markus, Sundström, Peter, Dahle, Charlotte, Vrethem, Magnus, Olsson, Tomas, Piehl, Fredrik, Norgren, Niklas, Rosengren, Lars, Svenningsson, Anders, Lycke, Jan

Volltext

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy von Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders

Volltext

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial von Piehl, Fredrik, Eriksson-Dufva, Ann, Budzianowska, Anna, Feresiadou, Amalia, Hansson, William, Hietala, Max Albert, Håkansson, Irene, Johansson, Rune, Jons, Daniel, Kmezic, Ivan, Lindberg, Christopher, Lindh, Jonas, Lundin, Fredrik, Nygren, Ingela, Punga, Anna Rostedt, Press, Rayomand, Samuelsson, Kristin, Sundström, Peter, Wickberg, Oskar, Brauner, Susanna, Frisell, Thomas

Volltext

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk von Tengvall, Katarina, Huang, Jesse, Hellström, Cecilia, Kammer, Patrick, Biström, Martin, Ayoglu, Burcu, Bomfim, Izaura Lima, Stridh, Pernilla, Butt, Julia, Brenner, Nicole, Michel, Angelika, Lundberg, Karin, Padyukov, Leonid, Lundberg, Ingrid E., Svenungsson, Elisabet, Ernberg, Ingemar, Olafsson, Sigurgeir, Dilthey, Alexander T., Hillert, Jan, Alfredsson, Lars, Sundström, Peter, Nilsson, Peter, Waterboer, Tim, Olsson, Tomas, Kockum, Ingrid

Volltext

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis von Axelsson, Markus, Malmeström, Clas, Gunnarsson, Martin, Zetterberg, Henrik, Sundström, Peter, Lycke, Jan, Svenningsson, Anders

Volltext

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase... von Svenningsson, Anders, Frisell, Thomas, Burman, Joachim, Salzer, Jonatan, Fink, Katharina, Hallberg, Susanna, Hambraeus, Joakim, Axelsson, Markus, Nimer, Faiez Al, Sundström, Peter, Gunnarsson, Martin, Johansson, Rune, Mellergård, Johan, Rosenstein, Igal, Ayad, Ahmad, Sjöblom, Irina, Risedal, Anette, de Flon, Pierre, Gilland, Eric, Lindeberg, Jonas, Shawket, Fadi, Piehl, Fredrik, Lycke, Jan

Volltext

Rituximab in multiple sclerosis von Salzer, J., Svenningsson, R., Alping, P., Novakova, Lenka, Björck, A., Fink, K., Islam-Jakobsson, P., Malmeström, Clas, Axelsson, Markus, Vågberg, M., Sundström, P., Lycke, Jan, Piehl, F., Svenningsson, A.

Volltext

The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age von Salzer, Jonatan, Stenlund, Hans, Sundström, Peter

Volltext

Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis von Ingvarsson, Jens, Grut, Viktor, Biström, Martin, Berg, Linn Persson, Stridh, Pernilla, Huang, Jesse, Hillert, Jan, Alfredsson, Lars, Kockum, Ingrid, Olsson, Tomas, Waterboer, Tim, Nilsson, Staffan, Sundström, Peter

Volltext

Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption von Gröning, Remigius, Dernstedt, Andy, Ahlm, Clas, Normark, Johan, Sundström, Peter, Forsell, Mattias N E

Volltext

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls von de Flon, Pierre, Söderström, Lars, Laurell, Katarina, Dring, Ann, Sundström, Peter, Gunnarsson, Martin, Svenningsson, Anders

Volltext

Response to ‘Mendelian randomization analysis does not support a role for leptin in multiple sclerosis’ von Biström, Martin, Hultdin, Johan, Sundström, Peter

Volltext

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study von Petersson, Malin, Feresiadou, Amalia, Jons, Daniel, Ilinca, Andreea, Lundin, Fredrik, Johansson, Rune, Budzianowska, Anna, Roos, Anna-Karin, Kågström, Viktor, Gunnarsson, Martin, Sundström, Peter, Piehl, Fredrik, Brauner, Susanna

Volltext

Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study von Grut, Viktor, Biström, Martin, Salzer, Jonatan, Stridh, Pernilla, Jons, Daniel, Gustafsson, Rasmus, Huang, Jesse, Bergström, Tomas, Kockum, Ingrid, Waterboer, Tim, Olsson, Tomas, Sundström, Peter

Volltext

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab von de Flon, Pierre, Gunnarsson, Martin, Laurell, Katarina, Söderström, Lars, Birgander, Richard, Lindqvist, Thomas, Krauss, Wolfgang, Dring, Ann, Bergman, Joakim, Sundström, Peter, Svenningsson, Anders

Volltext